Medical Device Firm Says Sabotage Suit Should Stand

Law360 | June 22, 2019 — Medical device company Neurvana told a Delaware vice chancellor Thursday it has enough to press its claim that Balt damaged potential revenue related to a neurovascular medical device purchased from Neurvana by dragging its feet in obtaining regulatory approvals.

Click to read the full article at